Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,709 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,356
Recruiting: 3,959
Ph III recruiting: 534
Growth YoY: +9.8%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,403)

clinicaltrialsPublishedShowing 1–50 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06084234	National Liver Cancer Screening Trial(TRACER)	recruiting	Phase 4	5,500	University of Texas Southwestern Medical CenterOTHER	1	Sep 25, 2026	clinicaltrials
NCT03340506	Dabrafenib and/or Trametinib Rollover Study	recruiting	Phase 4	100	Novartis PharmaceuticalsINDUSTRY	14	Sep 23, 2026	clinicaltrials